Evidence map›Paper›PMID 30898438›Full record

ArticleMolecular cell2019

MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis.

Pia-Amata Leimbacher, Samuel E Jones, Ann-Marie K Shorrocks, Mara de Marco Zompit, Matthew Day, Jordy Blaauwendraad, Diana Bundschuh, Sarah Bonham, Roman Fischer, Daniel Fink and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. PLK1 phosphorylates WRN at replication forks.The Journal of pharmacology and experimental therapeutics · 2025
    Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Pia-Amata LeimbacherDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland.
Samuel E JonesDepartment of Oncology, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Ann-Marie K ShorrocksDepartment of Oncology, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Mara de Marco ZompitDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland.
Matthew DayCancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer BN1 9RQ, UK.
Jordy BlaauwendraadDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland.
Diana BundschuhDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland.
Sarah BonhamTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Roman FischerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Daniel FinkDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland.
Benedikt M KesslerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Antony W OliverCancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer BN1 9RQ, UK.
Laurence H PearlCancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer BN1 9RQ, UK.
Andrew N BlackfordDepartment of Oncology, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK; Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK. Electronic address: andrew.blackford@oncology.ox.ac.uk.
Manuel StuckiDepartment of Gynecology, University Hospital and University of Zurich, Wagistrasse 14, 8952 Schlieren, Switzerland. Electronic address: manuel.stucki@uzh.ch.
University of Zurich · CHUniversity of Oxford · GBJohn Radcliffe Hospital · GBUniversity of Sussex · GBCancer Research UK · GB

Funding

Cancer Research UK 14532Cancer Research UK 20772Cancer Research UK 24386Cancer Research UK C29215/A20772Cancer Research UK C302/A24386Medical Research Council G0902418
6 · The paper itself

Abstract

In mitosis, cells inactivate DNA double-strand break (DSB) repair pathways to preserve genome stability. However, some early signaling events still occur, such as recruitment of the scaffold protein MDC1 to phosphorylated histone H2AX at DSBs. Yet, it remains unclear whether these events are important for maintaining genome stability during mitosis. Here, we identify a highly conserved protein-interaction surface in MDC1 that is phosphorylated by CK2 and recognized by the DNA-damage response mediator protein TOPBP1. Disruption of MDC1-TOPBP1 binding causes a specific loss of TOPBP1 recruitment to DSBs in mitotic but not interphase cells, accompanied by mitotic radiosensitivity, increased micronuclei, and chromosomal instability. Mechanistically, we find that TOPBP1 forms filamentous structures capable of bridging MDC1 foci in mitosis, indicating that MDC1-TOPBP1 complexes tether DSBs until repair is reactivated in the following G1 phase. Thus, we reveal an important, hitherto-unnoticed cooperation between MDC1 and TOPBP1 in maintaining genome stability during cell division.

Indexed as

Adaptor Proteins, Signal TransducingCarrier ProteinsCell Cycle ProteinsChromosomal InstabilityDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA RepairG1 PhaseGenome, HumanGenomic InstabilityHistonesHumansMitosisNuclear ProteinsPhosphorylationAdaptor Proteins, Signal TransducingCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsHistonesMDC1 protein, humanNuclear ProteinsTOPBP1 protein, humanTrans-Activators

Identifiers

PMID30898438
PMCPMC6509287
OpenAlexW2921197420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.